Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin PK in Healthy and Knee Arthritis Subjects
NCT04429880Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Peptides
01
Overview
Phase 2, open-label, single-arm trial of oxytocin in osteoarthritis (OA), sponsored by Wake Forest University Health Sciences. Primary endpoint: Pharmacokinetics of oxytocin in serum. Planned start Jan 2023; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04429880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429880.